As a crucial component of the modern healthcare system, in vitro diagnostics (IVD) have experienced rapid global growth in recent years. With the aging population, rising incidences of chronic diseases, and growing demand for precision medicine, the IVD industry is facing unprecedented growth opportunities.
From a technical perspective, IVD technology continues to innovate, expanding from traditional biochemical and immunodiagnostics to molecular diagnostics, point-of-care testing (POCT), and AI-assisted diagnosis. In particular, breakthroughs in gene sequencing, microfluidic chips, and biosensor technologies have significantly enhanced the sensitivity, accuracy, and convenience of IVD. For example, molecular diagnostics based on PCR and NGS enable early cancer screening and genetic disease detection, while POCT devices enable rapid diagnosis, playing a particularly important role in infectious disease prevention and control and primary care.
In terms of market demand, the global IVD market continues to grow. According to industry data, the global IVD market will exceed US$100 billion in 2023 and is expected to maintain an average annual growth rate of 5%-8% over the next few years. As the world's second-largest economy, China's IVD market is growing at a faster rate than the global average. Benefiting from national policy support (such as the "Healthy China 2030" strategy) and the shift of medical resources to lower-tier cities, domestic IVD companies are accelerating technological innovation and international expansion.
However, the industry also faces challenges, such as the continued dominance of multinational corporations in the high-end market, the reliance on imports for some core technologies, and tightening regulatory policies. Going forward, the IVD industry will increasingly rely on independent innovation, particularly in the areas of biomarker discovery, automated testing, and data integration and analysis. Furthermore, with the convergence of artificial intelligence and big data technologies, intelligent diagnostics will become a trend, further improving medical efficiency.
Overall, the IVD industry holds a promising future. Driven by both technological advancement and market demand, it will become a key growth driver in the healthcare industry. Companies that achieve breakthroughs in innovation and globalization strategies will have the potential to secure a leading position in future competition.